Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Robert F. Kennedy Jr. would have broad power as HHS secretary to strip vaccine makers' protections against lawsuits ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...

We have hardly begun to understand how inextricably our own health and safety are intertwined with those of our wild ...

While there will no doubt be plenty of competing GLP-1 drugs and weight loss products in the market in the future ... The 10 ...

Wegovy is being made available to Chinese patients five months after its approval in the country. Novo will sell the medicine ...

The New York Times reports on how despite the tough talk, the broken border has been a lifeline for America’s on-demand ...

Ozempic, a drug which contains the same active ingredient of semaglutide, was approved in 2021 and subsequently included on ...